{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:58:39Z","timestamp":1790186319957,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011404","name":"Indivior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011404","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jsat.2020.108267","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T12:09:15Z","timestamp":1609157355000},"page":"108267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration"],"prefix":"10.1016","volume":"123","author":[{"given":"Laura B.","family":"Monico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gryczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Dusek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjalee","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"DeVeaugh-Geiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Chilcoat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2020.108267_bb0005","series-title":"Provisional drug overdose death counts Atlanta, Georgia: National Center for Health Statistics, Centres for Disease Control and Prevention, 2018","author":"Ahmad","year":"2018"},{"key":"10.1016\/j.jsat.2020.108267_bb0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jsat.2016.08.002","article-title":"Non-prescribed buprenorphine in New York City: Motivations for use, practices of diversion, and experiences of stigma","volume":"70","author":"Allen","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2020.108267_bb0015","doi-asserted-by":"crossref","first-page":"108032","DOI":"10.1016\/j.jsat.2020.108032","article-title":"Buprenorphine waiver uptake among nurse practitioners and physician assistants: The role of existing waivered prescriber supply","volume":"115","author":"Auty","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2020.108267_bb0020","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugalcdep.2016.11.032","article-title":"Prescription opioid abuse in prison settings: A systematic review of prevalence, practice and treatment responses","volume":"171","author":"Bi-Mohammed","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"9","key":"10.1016\/j.jsat.2020.108267_bb0025","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2020.108267_bb0030","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1073110518782933","article-title":"Our ethical obligation to treat opioid use disorder in prisons: A patient and physician\u2019s perspective","volume":"46","author":"Bone","year":"2018","journal-title":"Journal of Law, Medicine, and Ethics"},{"issue":"2","key":"10.1016\/j.jsat.2020.108267_bb0035","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1080\/08897077.2019.1695706","article-title":"An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated","volume":"41","author":"Brezel","year":"2020","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2020.108267_bb0040","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.addbeh.2018.02.024","article-title":"Criminal justice continuum for opioid users at risk of overdose","volume":"86","author":"Brinkley-Rubinstein","year":"2018","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2020.108267_bb0045","unstructured":"Bronson, J., Stroop, J., Zimmer, S., & Berzofsky, M. (2017). Drug use, dependence, and abuse among state prisoners and jail inmates, 2007-2009. (Vol. NCJ 250546): Bureau of Justice Statistics."},{"issue":"1","key":"10.1016\/j.jsat.2020.108267_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drugpo.2007.11.019","article-title":"Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention","volume":"19","author":"Bruce","year":"2008","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.jsat.2020.108267_bb0055","series-title":"Multiple cause of death 1999\u20132018","author":"Centers for Disease Control and Prevention (CDC), & National Center for Health Statistics","year":"2019"},{"key":"10.1016\/j.jsat.2020.108267_bb0060","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jsat.2019.07.005","article-title":"Buprenorphine in the United States: Motives for abuse, misuse, and diversion","volume":"104","author":"Chilcoat","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2020.108267_bb0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2018.09.007","article-title":"Understanding the use of diverted buprenorphine","volume":"193","author":"Cicero","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2020.108267_bb0070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drugalcdep.2014.06.005","article-title":"Factors contributing to the rise of buprenorphine misuse: 2008\u20132013","volume":"142","author":"Cicero","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2020.108267_bb0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2105\/AJPH.2018.304852","article-title":"Criminal justice barriers to treatment of opioid use disorders in the United States: The need for public health advocacy","volume":"109","author":"Csete","year":"2019","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2020.108267_bb0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-7517-10-35","article-title":"Methadone treatment providers\u2019 views of drug court policy and practice: A case study of New York state","volume":"10","author":"Csete","year":"2013","journal-title":"Harm Reduction Journal"},{"issue":"2","key":"10.1016\/j.jsat.2020.108267_bb0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/08897077.2019.1572052","article-title":"Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?","volume":"40","author":"Doernberg","year":"2019","journal-title":"Substance Abuse"},{"issue":"2","key":"10.1016\/j.jsat.2020.108267_bb0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10610-017-9349-y","article-title":"Current and promising pharmacotherapies for substance use disorders among justice-involved populations","volume":"24","author":"Farabee","year":"2018","journal-title":"European Journal on Criminal Policy and Research"},{"issue":"1","key":"10.1016\/j.jsat.2020.108267_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): Availability, barriers, and intentions","volume":"33","author":"Friedmann","year":"2012","journal-title":"Substance Abuse"},{"issue":"12","key":"10.1016\/j.jsat.2020.108267_bb0100","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1016\/j.addbeh.2013.08.008","article-title":"Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland","volume":"38","author":"Genberg","year":"2013","journal-title":"Addictive Behaviors"},{"issue":"2","key":"10.1016\/j.jsat.2020.108267_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14659890701680786","article-title":"Subutex snorters: A case series","volume":"13","author":"George","year":"2008","journal-title":"Journal of Substance Use"},{"issue":"2","key":"10.1016\/j.jsat.2020.108267_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0217","article-title":"The burden of opioid-related mortality in the United States","volume":"1","author":"Gomes","year":"2018","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.jsat.2020.108267_bb0115","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.drugalcdep.2018.04.010","article-title":"Initiating buprenorphine treatment prior to versus after release from prison: Arrest outcomes","volume":"188","author":"Gordon","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2020.108267_bb0120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2016.11.037","article-title":"A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release","volume":"172","author":"Gordon","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2020.108267_bb0125","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","article-title":"Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system","volume":"75","author":"Green","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.jsat.2020.108267_bb0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1521-0391.2012.12004.x","article-title":"Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system","volume":"22","author":"Gryczynski","year":"2013","journal-title":"American Journal of Addiction"},{"key":"10.1016\/j.jsat.2020.108267_bb0135","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999-2017","volume":"329","author":"Hedegaard","year":"2018","journal-title":"NCHS Data Brief"},{"issue":"1\u20133","key":"10.1016\/j.jsat.2020.108267_bb0140","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2011.07.019","article-title":"Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians","volume":"120","author":"Johanson","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2020.108267_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13722-019-0145-5","article-title":"A conceptual model for understanding post-release opioid-related overdose risk","volume":"14","author":"Joudrey","year":"2019","journal-title":"Addiction Science & Clinical Practice"},{"issue":"17","key":"10.1016\/j.jsat.2020.108267_bb0150","doi-asserted-by":"crossref","first-page":"388","DOI":"10.15585\/mmwr.mm6817a3","article-title":"Drug overdose deaths involving cocaine and psychostimulants with abuse potential - United States, 2003\u20132017","volume":"68","author":"Kariisa","year":"2019","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"2","key":"10.1016\/j.jsat.2020.108267_bb0155","first-page":"13","article-title":"Harm-reduction activism: A case study of an unsanctioned user-run safe injection site","volume":"9","author":"Kerr","year":"2004","journal-title":"Canadian HIV\/AIDS Policy and Law Review"},{"issue":"4","key":"10.1016\/j.jsat.2020.108267_bb0160","doi-asserted-by":"crossref","first-page":"644","DOI":"10.15288\/jsad.2015.76.644","article-title":"The supply of physicians waivered to prescribe buprenorphine for opioid use disorders in the United States: A state-level analysis","volume":"76","author":"Knudsen","year":"2015","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"1","key":"10.1016\/j.jsat.2020.108267_bb0165","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/PAF.0b013e3181873784","article-title":"Drugs, detention, and death: A study of the mortality of recently released prisoners","volume":"30","author":"Krinsky","year":"2009","journal-title":"American Journal of Forensic Medicine and Pathology"},{"issue":"1","key":"10.1016\/j.jsat.2020.108267_bb0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsat.2014.02.003","article-title":"Abuse and diversion of buprenorphine sublingual tablets and film","volume":"47","author":"Lavonas","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.jsat.2020.108267_bb0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000045","article-title":"A review of buprenorphine diversion and misuse: The current evidence base and experiences from around the world","volume":"8","author":"Lofwall","year":"2014","journal-title":"Journal of Addiction Medicine"},{"issue":"5","key":"10.1016\/j.jsat.2020.108267_bb0180","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jsat.2012.10.004","article-title":"Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes","volume":"44","author":"Matusow","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2020.108267_bb0185","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.drugpo.2019.06.019","article-title":"\u201cThey\u2019re making it so hard for people to get help:\u201d Motivations for non-prescribed buprenorphine use in a time of treatment expansion","volume":"71","author":"McLean","year":"2019","journal-title":"The International Journal on Drug Policy"},{"issue":"9","key":"10.1016\/j.jsat.2020.108267_bb0190","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.jsat.2020.108267_bb0195","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/10550490903077820","article-title":"Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland","volume":"18","author":"Mitchell","year":"2009","journal-title":"American Journal of Addiction"},{"key":"10.1016\/j.jsat.2020.108267_bb0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2015.04.010","article-title":"Prior experience with non-prescribed buprenorphine: Role in treatment entry and retention","volume":"57","author":"Monico","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2020.108267_bb0205","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/10550880903014767","article-title":"Diversion of buprenorphine\/naloxone coformulated tablets in a region with high prescribing prevalence","volume":"28","author":"Monte","year":"2009","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2020.108267_bb0210","series-title":"Tackling prison drug markets: An exploratory qualitative study. Home Office online report 39\/05","author":"Penfold","year":"2005"},{"key":"10.1016\/j.jsat.2020.108267_bb0215","series-title":"Opioid use disorder treatment in jails and prisons: Medication provided to incarcerated populations saves lives","author":"Pew Charitable Trusts","year":"2020"},{"issue":"5152","key":"10.1016\/j.jsat.2020.108267_bb0220","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths - United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"1","key":"10.1016\/j.jsat.2020.108267_bb0225","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsat.2010.03.014","article-title":"Self-treatment: Illicit buprenorphine use by opioid-dependent treatment seekers","volume":"39","author":"Schuman-Olivier","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"7129","key":"10.1016\/j.jsat.2020.108267_bb0230","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/bmj.316.7129.426","article-title":"Mortality from overdose among injecting drug users recently released from prison: Database linkage study","volume":"316","author":"Seaman","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jsat.2020.108267_bb0235","series-title":"Medication-assisted treatment (MAT) in the criminal justice system: Brief guidance to the states (HHS Publication No. PEP19-MATBRIEFCJS)","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2019"},{"issue":"2","key":"10.1016\/j.jsat.2020.108267_bb0240","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/17449200902880482","article-title":"Exploring prison buprenorphine misuse in the United Kingdom: A qualitative study of former prisoners","volume":"5","author":"Tompkins","year":"2009","journal-title":"International Journal of Prison Health"},{"issue":"1","key":"10.1016\/j.jsat.2020.108267_bb0245","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/dar.12317","article-title":"The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film","volume":"35","author":"White","year":"2016","journal-title":"Drug and Alcohol Review"},{"issue":"3","key":"10.1016\/j.jsat.2020.108267_bb0255","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0558","article-title":"Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use","volume":"1","author":"Winkelman","year":"2018","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.jsat.2020.108267_bb0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/10550887.2011.642757","article-title":"The emerging buprenorphine epidemic in the United States","volume":"31","author":"Wish","year":"2012","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"10.1016\/j.jsat.2020.108267_bb0265","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: An international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Current Drug Abuse Reviews"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547220305249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547220305249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:52:39Z","timestamp":1760039559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547220305249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":52,"alternative-id":["S0740547220305249"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108267","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108267"}}